A Phase 1, Placebo-Controlled Trial to Evaluate the Impact of Intravenous (IV) Bendavia (MTP-131) on Endothelial Reactivity Dysfunction Induced by Cigarette Smoking

Trial Profile

A Phase 1, Placebo-Controlled Trial to Evaluate the Impact of Intravenous (IV) Bendavia (MTP-131) on Endothelial Reactivity Dysfunction Induced by Cigarette Smoking

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Jun 2015

At a glance

  • Drugs Elamipretide (Primary)
  • Indications Cardiovascular disorders
  • Focus Pharmacodynamics
  • Sponsors Stealth Peptides
  • Most Recent Events

    • 17 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top